Clinical and Ultrasonographic Evaluation of the Efficacy of Extracorporeal Shock Wave Therapy (ESWT) in Post-Stroke Spasticity
Recruiting
N/A
Interventional Study
Stroke
Spastic Hemiplegia
Extracorporal Shockwave Therapy (ESWT)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 35 – 65
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 32 (estimated)
- Sponsor
- Pamukkale University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This research evaluate the effectiveness of Extracorporeal Shock Wave Therapy (ESWT) for treating spasticity in the wrist flexor muscles (flexor carpi ulnaris - FCU and flexor carpi radialis - FCR) of chronic stroke patients.
Spasticity, a common complication after a stroke, causes muscle stiffness, pain, and functional limitation, leading to increased healthcare costs and a lower quality of life…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age between 35 and 65 years.
* First-ever stroke episode confirmed by MRI and/or CT scan.
* Clinical diagnosis of hemiplegia.
* More than 6 months post-stroke.
* A Modified Ashworth Scale (MAS) score between 1 and 3 for wrist flexor spasticity.
Exclusion Criteria:
* History …
Contacts